CME Group Inc. (NASDAQ:CME) Shares Bought by Choreo LLC

Choreo LLC increased its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 66.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,024 shares of the financial services provider's stock after purchasing an additional 4,387 shares during the period. Choreo LLC's holdings in CME Group were worth $2,924,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. SeaCrest Wealth Management LLC lifted its holdings in shares of CME Group by 3.0% in the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock worth $366,000 after acquiring an additional 40 shares during the last quarter. New Age Alpha Advisors LLC lifted its holdings in shares of CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after acquiring an additional 43 shares during the last quarter. OneAscent Financial Services LLC lifted its holdings in shares of CME Group by 4.0% in the 1st quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider's stock worth $293,000 after acquiring an additional 43 shares during the last quarter. Ballentine Partners LLC lifted its holdings in shares of CME Group by 0.8% in the 1st quarter. Ballentine Partners LLC now owns 5,828 shares of the financial services provider's stock worth $1,546,000 after acquiring an additional 45 shares during the last quarter. Finally, Wealthcare Advisory Partners LLC lifted its holdings in shares of CME Group by 3.6% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock worth $356,000 after acquiring an additional 47 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. Piper Sandler raised their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. JPMorgan Chase & Co. lowered their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Royal Bank Of Canada reissued a "sector perform" rating and issued a $269.00 price objective on shares of CME Group in a research note on Thursday, April 3rd. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, CME Group currently has an average rating of "Hold" and an average target price of $261.93.

Insider Buying and Selling

In other news, Director Dennis Suskind sold 1,000 shares of the company's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total transaction of $271,280.00. Following the transaction, the director directly owned 2,915 shares of the company's stock, valued at $790,781.20. This represents a 25.54% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Charles P. Carey sold 3,000 shares of the stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $272.56, for a total transaction of $817,680.00. Following the completion of the sale, the director directly owned 5,400 shares in the company, valued at approximately $1,471,824. The trade was a 35.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,400 shares of company stock worth $3,152,410 in the last ninety days. Insiders own 0.30% of the company's stock.

CME Group Stock Up 0.9%

Shares of NASDAQ:CME traded up $2.37 during trading on Friday, hitting $279.55. 1,834,736 shares of the company were exchanged, compared to its average volume of 2,117,443. The stock has a market capitalization of $100.74 billion, a P/E ratio of 27.06, a PEG ratio of 4.85 and a beta of 0.44. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 12-month low of $193.25 and a 12-month high of $290.79. The firm's 50 day moving average price is $276.44 and its 200-day moving average price is $262.25.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.56 EPS. On average, research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were paid a $1.25 dividend. The ex-dividend date was Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.79%. CME Group's dividend payout ratio is currently 48.40%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.